What Happened?
Baltimore, MD-based WindMIL Therapeutics Promoted Kimberly Noonan as Executive Vice President and Chief Science and Technology Officer
About the Company
WindMIL Therapeutics is a clinical stage oncology cell therapy company. We are leveraging our proprietary platform to develop a novel class of cell therapies called MILs™ (Marrow Infiltrating Lymphocytes) derived from memory T cells found in the bone marrow.
About the Person
Kimberly Noonan is Executive Vice President and Chief Science and Technology Officer at WindMIL Therapeutics. Previously, Kimberly held various senior IT leadership roles in the industry.
Info Source
News
Short Profile